Opal, Steven M <br/><br/>
Orally administered recombinant human interleukin-11 is protective in experimental neutropenic sepsis.  [electronic resource] 

 -  The Journal of infectious diseases  Jan 2003 
 - 70-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-1899 
<br/><br/><label>Standard No.: </label>10.1086/345864  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Animals<br/>Bacteremia--prevention & control<br/>Female<br/>Interferon-gamma--genetics<br/>Interleukin-11--administration & dosage<br/>Neutropenia--drug therapy<br/>RNA, Messenger--analysis<br/>Rats<br/>Rats, Sprague-Dawley<br/>Recombinant Proteins--administration & dosage<br/>Tumor Necrosis Factor-alpha--genetics